MedPath

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Phase 2
Terminated
Conditions
Autism Spectrum Disorder (ASD)
Autistic Disorder
Autism
Asperger's Disorder
Asperger's
Pediatric Autism
Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Interventions
Registration Number
NCT01592773
Lead Sponsor
Forest Laboratories
Brief Summary

The objective of this study is to evaluate the long-term safety and tolerability of memantine in the treatment of pediatric patients with autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS).

Detailed Description

This clinical study was a 48-week, multicenter, multinational, open-label extension study in pediatric outpatients with autism, Asperger's Disorder, or PDD-NOS conducted at 106 study centers. Patients were eligible for this long-term extension study if they had:

* completed the open-label Study MEM MD 67,or

* completed the open-label Study MEM-MD-91, or

* completed the double-blind Study MEM-MD-68, or

* discontinued study MEM-MD-68 by meeting requirements for loss of therapeutic response

The weight-based dose limits in this study were as follows:

Group A: ≥ 60 kg; maximum 15 mg/day Group B: 40-59 kg; maximum 9 mg/day Group C: 20-39 kg; maximum 6 mg/day Group D: \< 20 kg; maximum 3 mg/day

The decision to close the study early was based on data from 2 double-blind placebo-controlled studies (MEM-MD-57A and MEM-MD-68) that failed to demonstrate a statistically significant difference between memantine and placebo in the primary efficacy parameter based on Social Responsiveness Scale (SRS) total raw score.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
747
Inclusion Criteria
  • Patients who completed Study MEM-MD-67, MEM-MD-68, MEM-MD-91, or discontinued Study MEM-MD-68 due to meeting the criterion for loss of therapeutic response.
  • Having normal results from a physical examination and laboratory tests at Visit 1 of this study (last visit of the preceding study). Any abnormal findings must be deemed not clinically significant by the Investigator and documented as such.
  • Have a family that is sufficiently organized and stable to guarantee adequate safety monitoring and continuous attendance to clinic visits for the duration of the study
Exclusion Criteria
  • Patients who discontinued a preceding memantine study due to an adverse event possibly related to study drug
  • Patients with a concurrent medical condition that might interfere with the conduct of the study, confound interpretation of the study results, or endanger the patient's well being
  • Significant risk of suicidality based on the Investigator's judgment, Aberrant Behavior Checklist-irritability subscale (ABC-I), or if appropriate, as indicated by a response of "yes" to questions 4 or 5 in the suicidal ideation section of the Children's Columbia-Suicide Severity Rating Scale (C-SSRS) or any suicidal behavior

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MemantineMemantine Hydrochloride (HCl)To maintain the blind of the preceding study, patients who participated in MEM-MD-68 (NCT01592747) began this study with 6 weeks of double blind dosing during which all patients were either titrated to or remained on their maximum target dosages. This was followed by up-to 42 weeks of open-label dosing. Patients who took open-label memantine in study MEM-MD-67 (NCT01999894) or MEM-MD-91(NCT01592786), received up to 48 weeks of open-label memantine at their maximum tolerated weight based target dosage.
Primary Outcome Measures
NameTimeMethod
Patients With Any Treatment-emergent Adverse EventVisit 1 (Week 0) up to 30 days after Visit 8 (up to Week 48) or Final Visit

Number of patients who experienced 1 or more Treatment Emergent Adverse Event

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (106)

Forest Investigative Site 116

🇺🇸

Lincoln, Nebraska, United States

Forest Investigative Site 579

🇵🇱

Gdansk, Poland

Forest Investigative Site 576

🇵🇱

Tyniec Maly, Poland

Forest Investigative Site 096

🇺🇸

Los Angeles, California, United States

Forest Investigative Site 676

🇿🇦

Bellville Cape Town, South Africa

Forest Investigative Site 226

🇨🇴

Bogota, Colombia

Forest Investigative Site 627

🇷🇸

Belgrade, Serbia

Forest Investigative Site 629

🇷🇸

Nis, Serbia

Forest Investigative Site 097

🇺🇸

Lincoln, Nebraska, United States

Forest Investigative Site 082

🇺🇸

Evansville, Indiana, United States

Forest Investigative Site 086

🇺🇸

Rockville, Maryland, United States

Forest Investigative Site 136

🇺🇸

Neptune, New Jersey, United States

Forest Investigative Site 203

🇧🇪

Jette, Belgium

Forest Investigative Site 081

🇺🇸

Albuquerque, New Mexico, United States

Forest Investigative Site 023

🇺🇸

Naperville, Illinois, United States

Forest Investigative Site 127

🇺🇸

Toms River, New Jersey, United States

Forest Investigative Site 069

🇺🇸

Avon Lake, Ohio, United States

Forest Investigative Site 115

🇺🇸

Orange City, Florida, United States

Forest Investigative Site 002

🇺🇸

Stanford, California, United States

Forest Investigative Site 801

🇺🇦

Odessa, Ukraine

Forest Investigative Site 001

🇺🇸

Columbus, Ohio, United States

Forest Investigative Site 107

🇺🇸

Albuquerque, New Mexico, United States

Forest Investigative Site 059

🇺🇸

Newton, Massachusetts, United States

Forest Investigative Site 102

🇺🇸

Libertyville, Illinois, United States

Forest Investigative Site 453

🇮🇹

Roma, Italy

Forest Investigative Site 092

🇺🇸

Tulsa, Oklahoma, United States

Forest Investigative Site 119

🇺🇸

Charleston, West Virginia, United States

Forest Investigative Site 113

🇺🇸

Norfolk, Virginia, United States

Forest Investigative Site 703

🇰🇷

Seoul, Korea, Republic of

Forest Investigative Site 704

🇰🇷

Yangsan-si, Gyeongsangnam-do, Korea, Republic of

Forest Investigative Site 070

🇺🇸

The Woodlands, Texas, United States

Forest Investigative Site 124

🇺🇸

Roanoke, Virginia, United States

Forest Investigative Site 063

🇺🇸

Middleton, Wisconsin, United States

Forest Investigative Site 329

🇫🇷

Bron Cedex, Rhone, France

Forest Investigative Site 382

🇭🇺

Gyula, Hungary

Forest Investigative Site 526

🇳🇿

Wellington, New Zealand

Forest Investigative Site 578

🇵🇱

Gdansk, Poland

Forest Investigative Site 452

🇮🇹

Siena, Italy

Forest Investigative Site 702

🇰🇷

Seoul, Korea, Republic of

Forest Investigative Site 577

🇵🇱

Warsaw, Poland

Forest Investigative Site 701

🇰🇷

Seoul, Korea, Republic of

Forest Investigative Site 730

🇪🇸

Torremolinos, Spain

Forest Investigative Site 056

🇺🇸

Indianapolis, Indiana, United States

Forest Investigative Site 052

🇺🇸

Washington, District of Columbia, United States

Forest Investigative Site 085

🇺🇸

Oakland Park, Florida, United States

Forest Investigative Site 055

🇺🇸

Tucson, Arizona, United States

Forest Investigative Site 077

🇺🇸

Little Rock, Arkansas, United States

Forest Investigative Site 068

🇺🇸

Dothan, Alabama, United States

Forest Investigative Site 109

🇺🇸

Imperial, California, United States

Forest Investigative Site 066

🇺🇸

Irvine, California, United States

Forest Investigative Site 026

🇺🇸

Santa Ana, California, United States

Forest Investigative Site 078

🇺🇸

Boulder, Colorado, United States

Forest Investigative Site 073

🇺🇸

Centennial, Colorado, United States

Forest Investigative Site 075

🇺🇸

Bradenton, Florida, United States

Forest Investigative Site 117

🇺🇸

Jacksonville, Florida, United States

Forest Investigative Site 118

🇺🇸

Miami, Florida, United States

Forest Investigative Site 155

🇨🇦

Toronto, Ontario, Canada

Forest Investigative Site 071

🇺🇸

Bothell, Washington, United States

Forest Investigative Site 376

🇭🇺

Budapest, Hungary

Forest Investigative Site 728

🇪🇸

Sabadell, Spain

Forest Investigative Site 381

🇭🇺

Budapest, Hungary

Forest Investigative Site 729

🇪🇸

Barcelona, Spain

Forest Investigative Site 123

🇺🇸

Fort Wayne, Indiana, United States

Forest Investigative Site 095

🇺🇸

Lake Charles, Louisiana, United States

Forest Investigative Site 054

🇺🇸

Glendale, California, United States

Forest Investigative Site 065

🇺🇸

Maitland, Florida, United States

Forest Investigative Site 064

🇺🇸

Charlottesville, Virginia, United States

Forest Investigative Site 108

🇺🇸

Springfield, Massachusetts, United States

Forest Investigative Site 090

🇺🇸

Memphis, Tennessee, United States

Forest Investigative Site 132

🇺🇸

Johnstown, Pennsylvania, United States

Forest Investigative Site 053

🇺🇸

Gresham, Oregon, United States

Forest Investigative Site 100

🇺🇸

Media, Pennsylvania, United States

Forest Investigative Site 051

🇺🇸

Houston, Texas, United States

Forest Investigative Site 028

🇺🇸

Clinton, Utah, United States

Forest Investigative Site 130

🇺🇸

Henderson, Nevada, United States

Forest Investigative Site 131

🇺🇸

McMurray, Pennsylvania, United States

Forest Investigative Site 141

🇺🇸

Ogden, Utah, United States

Forest Investigative Site 378

🇭🇺

Budapest, Hungary

Forest Investigative Site 021

🇺🇸

San Francisco, California, United States

Forest Investigative Site 005

🇺🇸

Phoenix, Arizona, United States

Forest Investigative Site 057

🇺🇸

Nashville, Tennessee, United States

Forest Investigative Site 125

🇺🇸

Orlando, Florida, United States

Forest Investigative Site 062

🇺🇸

Orlando, Florida, United States

Forest Investigative Site 067

🇺🇸

Tampa, Florida, United States

Forest Investigative Site 061

🇺🇸

Louisville, Kentucky, United States

Forest Investigative Site 104

🇺🇸

Las Vegas, Nevada, United States

Forest Investigative Site 019

🇺🇸

Oklahoma City, Oklahoma, United States

Forest Investigative Site 029

🇺🇸

Salt Lake City, Utah, United States

Forest Investigative Site 276

🇪🇪

Tallinn, Estonia

Forest Investigative Site 580

🇵🇱

Kielce, Poland

Forest Investigative Site 626

🇷🇸

Belgrade, Serbia

Forest Investigative Site 628

🇷🇸

Novi Sad, Serbia

Forest Investigative Site 227

🇨🇴

Barranquilla, Colombia

Forest Investigative Site 401

🇮🇸

Kopavogur, Iceland

Forest Investigative Site 228

🇨🇴

Antioquia, Bello, Colombia

Forest Investigative Site 803

🇺🇦

Donetsk, Ukraine

Forest Investigative Site 807

🇺🇦

Kharkiv, Ukraine

Forest Investigative Site 802

🇺🇦

Kherson, Ukraine

Forest Investigative Site 804

🇺🇦

Kyiv, Ukraine

Forest Investigative Site 204

🇧🇪

Brussels, Belgium

Forest Investigative Site 080

🇺🇸

Gainesville, Florida, United States

Forest Investigative Site 091

🇺🇸

New Orleans, Louisiana, United States

Forest Investigative Site 072

🇺🇸

Chapel Hill, North Carolina, United States

Forest Investigative Site 105

🇺🇸

Charleston, South Carolina, United States

Forest Investigative Site 098

🇺🇸

Bronx, New York, United States

Forest Investigative Site 101

🇺🇸

Wellington, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath